Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
- PMID: 18305141
- DOI: 10.2337/db07-1403
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Abstract
Objective: Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases.
Research design and methods: We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect.
Results: We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat-fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14(-)(/)(-) mutant mice mimicked the metabolic and inflammatory effects of antibiotics.
Conclusions: This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Similar articles
-
Metabolic endotoxemia initiates obesity and insulin resistance.Diabetes. 2007 Jul;56(7):1761-72. doi: 10.2337/db06-1491. Epub 2007 Apr 24. Diabetes. 2007. PMID: 17456850
-
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.FASEB J. 2008 Jul;22(7):2416-26. doi: 10.1096/fj.07-102723. Epub 2008 Mar 7. FASEB J. 2008. PMID: 18326786
-
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.Gut. 2009 Aug;58(8):1091-103. doi: 10.1136/gut.2008.165886. Epub 2009 Feb 24. Gut. 2009. PMID: 19240062 Free PMC article.
-
Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Epub 2011 Aug 1. JPEN J Parenter Enteral Nutr. 2011. PMID: 21807932 Review.
-
Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.Pathol Biol (Paris). 2008 Jul;56(5):305-9. doi: 10.1016/j.patbio.2007.09.008. Epub 2008 Jan 30. Pathol Biol (Paris). 2008. PMID: 18178333 Review.
Cited by
-
Gut microbiota and old age: Modulating factors and interventions for healthy longevity.Exp Gerontol. 2020 Nov;141:111095. doi: 10.1016/j.exger.2020.111095. Epub 2020 Sep 23. Exp Gerontol. 2020. PMID: 32979504 Free PMC article. Review.
-
GPR43 Potentiates β-Cell Function in Obesity.Diabetes. 2015 Sep;64(9):3203-17. doi: 10.2337/db14-1938. Epub 2015 May 28. Diabetes. 2015. PMID: 26023106 Free PMC article.
-
Composition of dietary fat source shapes gut microbiota architecture and alters host inflammatory mediators in mouse adipose tissue.JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):746-54. doi: 10.1177/0148607113486931. Epub 2013 May 2. JPEN J Parenter Enteral Nutr. 2013. PMID: 23639897 Free PMC article.
-
Effects of dietary fibre on metabolic health and obesity.Nat Rev Gastroenterol Hepatol. 2024 May;21(5):301-318. doi: 10.1038/s41575-023-00891-z. Epub 2024 Feb 7. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38326443 Review.
-
The Role of PPARγ Gene Polymorphisms, Gut Microbiota in Type 2 Diabetes: Current Progress and Future Prospects.Diabetes Metab Syndr Obes. 2023 Nov 7;16:3557-3566. doi: 10.2147/DMSO.S429825. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37954888 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous